Relaxing effects of Nifedipine on the nonpregnant human uterus in vitro and in vivo

Obstetrics & Gynecology · 1978 · vol. 52(4) , pp. 436–41 · PMID:714325 · W2433781576
Other OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-02 ⓘ

Nifedipine inhibited spontaneous myometrial activity and relaxed potassium-contracted strips in vitro, while orally administered doses effectively reduced uterine contraction amplitude, frequency, and basal tone in healthy women during early menstruation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The effects of the calcium antagonist Nifedipine were investigated on isolated human myometrium and on uterine activity in healthy women during their first menstrual days. Nifedipine (0.01-1.0 microgram/ml) had a concentration-related inhibiting effect on spontaneous activity of the myometrial strips, and relaxed preparations contracted by potassium. In vivo, Nifedipine (20-30 mg) given orally, effectively and rapidly reduced uterine activity, decreasing both amplitude and frequency of uterine contractions, and reduced basal tone. A moderate increase in heart rate and a transient facial flushing were noted, but otherwise no side effects were observed. Calcium antagonists like Nifedipine represent a new approach to the problem of relaxing the myometrium, and might be an interesting therapeutic alternative in situations where inhibition of unwanted uterine activity is desirable.

My notes (saved in your browser only)

MeSH descriptors

Nifedipine Pyridines Uterus Adult Face Face Female Heart Rate Heart Rate Humans Menstruation Middle Aged Myometrium Myometrium Nifedipine Nifedipine Potassium Potassium Pyridines Uterine Contraction

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:37.372514+00:00
License: CC0 · commercial use OK